Brief: Moberg Pharma, Karo Healthcare Expand Collaboration
April 24 (Reuters) - Moberg Pharma AB (publ) MBPH.ST: MOBERG PHARMA AND KARO HEALTHCARE EXPAND COLLABORATION FOR MOB-015/TERCLARA TO AUSTRALIA, NEW ZEALAND, SOUTH KOREA AND TAIWAN FINANCIAL TERMS ARE NOT DISCLOSED AGREEMENT INCLUDES ROYALTY REVENUES AND COMPENSATION FOR DELIVERED PRODUCTS Source text: ID:nWkr4TRHNK Further company coverage: MBPH.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Moberg Pharma AB (publ)
See all newsSweden's Moberg Pharma Q2 loss narrows as revenue rises
Brief: Moberg Pharma Q2 EBITDA SEK -4.3 Million
Brief: Moberg Pharma Names Vaidrius Navikas Chief Medical Officer
Brief: Moberg Pharma And Karo Healthcare Expand Collaboration
Moberg Pharma Q1 revenue rises, losses narrow on Nordic market share gains